Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

Houston company testing drug to protect against COVID 19

Posted on May 8, 2020May 8, 2020 by Brenton Scott
Posted in News Coverage

Post navigation

Pulmotect receives FDA approval to commence two Phase-2 trials targeting COVID-19
Houston biotech company gets green light from FDA to test coronavirus-fighting drug
Pulmotect Inc

10401 Town Park Drive
Houston, TX 77072
Contact Us

© 2026
Pulmotect, Inc.